US court to weigh Obamacare mandate to cover HIV drug, cancer screenings
Send a link to a friend
[March 04, 2024]
By Brendan Pierson
(Reuters) - President Joe Biden's administration on Monday is set to
urge a U.S. appeals court to preserve a federal mandate that requires
health insurers to cover preventive care services including
HIV-preventing medication and cancer screenings at no extra cost to
patients.
The preventive care mandate, which covers a wide range of services
chosen by a federal task force, is part of the 2010 Affordable Care Act
(ACA), often called Obamacare because it was championed by
then-President Barack Obama.
The arguments scheduled before a three-judge panel of the New
Orleans-based 5th U.S. Circuit Court of Appeals on Monday stem from a
lawsuit brought by a group of businesses, including Texas-based
Christian wellness center operator Braidwood Management, objecting to
the requirement that they provide coverage for HIV pre-exposure
prophylaxis (PrEP).
Braidwood and the other plaintiffs sued specifically over mandatory
coverage for PrEP, which they said violates their religious beliefs by
encouraging homosexuality and drug use.
The PrEP drugs approved in the United States to prevent HIV infection,
which can cause AIDS, are made by Gilead Sciences and by ViiV
Healthcare, a joint venture of GSK, Pfizer and Shionogi.
U.S. District Judge Reed O'Connor in Fort Worth in March 2023 went
further than the plaintiffs had asked, blocking the federal government
from enforcing the mandate for a wide range of services. O'Connor found
that the law gave the members of the task force that chooses which
services should be covered too much power for officials who are not
appointed by the president and confirmed by the Senate, violating the
U.S. Constitution.
[to top of second column]
|
A sign on an insurance store advertises Obamacare in San Ysidro, San
Diego, California, U.S., October 26, 2017. REUTERS/Mike Blake/File
Photo
O'Connor's ruling is largely on hold
under an agreement between Braidwood and Biden's administration
while the appeal proceeds, but allows Braidwood itself not to cover
PrEP.
If O'Connor's ruling is allowed to take effect, insurers would be
able to charge patients co-pays and deductibles for preventive
services.
The ruling does not apply to services the task force recommended
before the ACA was enacted in 2010, including breast cancer
screening.
Two members of the 5th Circuit panel, Circuit Judges Don Willett and
Cory Wilson, were appointed by Republican former President Donald
Trump, and the third, Circuit Judge Irma Carrillo Ramirez, was
appointed by Biden, a Democrat.
O'Connor previously drew attention in 2018 for striking down all of
Obamacare. That ruling was largely reversed by the 5th Circuit, and
then completely reversed by the U.S. Supreme Court.
(Reporting by Brendan Pierson in New York; Editing by Will Dunham
and Alexia Garamfalvi)
[© 2024 Thomson Reuters. All rights reserved.]This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|